Trial Profile
Open-label extension study for patients with severe chronic lower back pain or severe chronic pain due to osteoarthritis of the knee who have completed any of the previous clinical trials of phase IIIb tapentadol hydrochloride KF5503/42 codes, KF5503/43, KF5503/44 or KF5503 / 45. [Estudio abierto de extensión para los pacientes con lumbalgia crónica severa o dolor crónico severo debido a artrosis de rodilla que han completado alguno de los ensayos clínicos previos de fase IIIb de clorhidrato de tapentadol códigos KF5503/42, KF5503/43, KF5503/44 o KF5503/45.]
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Jun 2011
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Grunenthal
- 09 Jun 2011 New trial record